Koesten, Hirschmann & Crabtree, Inc. Charles River Laboratories International, Inc. Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $156 Billion
- Q1 2024
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 8 shares of CRL stock, worth $1,652. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8Holding current value
$1,652% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
727Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.25 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.07 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$433 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$388 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$313 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.5B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...